$3335 | Single User
$3680 | Site License
$5520 | Enterprise License

Europe Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
[Report Updated: 01-12-2016]

Published by Market Data Forecast: 01 Dec 2016 | 49378 | In Stock
Related Topics: Boehringer Ingelheim , Novartis , Protein , Veterinary

Introduction

The Europe animal vaccines market is poised to reach 40.82 Million by 2020 from 93.64 Million in 2015, at a CAGR of 4.97% from 2015 to 2020. Vaccination protects animals from specific infectious diseases and may be carried out either routinely or potentially in an emergency. Vaccination of animals used for food can also help protect consumers against zoonotic pathogens such as salmonella.

Veterinary vaccine market in Europe is as old as the concept itself and newest products are significantly available throughout the market. The farmers and animal husbandry owners seem well versed with the idea of animal vaccination. But the real test lies in the stringent guidelines for animal vaccines testing as per EU regulations. This prevents or at least hardens the route for new players to enter the market. Also the market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermenter technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.

Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans; increasing investments by leading players, various government agencies and animal associations; continuous innovations, increasing awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into development of new products. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.

The Europe veterinary vaccines market, based on production technologies, has been segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. Further, based on Animal Type, it has been segmented into livestock and companion vaccines. The livestock vaccines segment contains five categories namely, bovine, porcine, ovine, poultry and equine. The bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. Similarly, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France. European region is leading the veterinary vaccine market in terms of consumption.

Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.

Table of Contents
for Europe Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) [Report Updated: 01-12-2016]

  • Introduction

    1.1 Market Definition

    1.2 Study Deliverables

    1.3 Base Currency, Base Year and Forecast Periods

    1.4 General Study Assumptions

    Research Methodology

    2.1 Introduction

    2.2 Analysis Design

    2.3 Research Phases

    2.3.1 Secondary Research

    2.3.2 Primary Research

    2.3.3 Econometric Modelling

    2.3.4 Expert Validation

    2.4 Study Timeline

    Overview

    3.1 Executive Summary

    3.2 Key Inferences

    3.3 New Developments

    Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

    4.1 Market Drivers

    4.2 Market Restraints

    4.3 Key Challenges

    4.4 Current Opportunities in the Market

    Market Segmentation

    5.1 By Type

    5.1.1 Livestock vaccines

    5.1.1.1 Bovine

    5.1.1.2 Porcine

    5.1.1.3 Ovine

    5.1.1.4 Poultry

    5.1.1.5 Equine

    5.1.2 Companion vaccines

    5.1.2.1 Canine

    5.1.2.2 Feline

    5.2 Technology

    5.2.1 Live attenuated vaccines

    5.2.2 Inactivated vaccines

    5.2.3 Recombinant vaccines

    5.2.4 Toxoid vaccines

    5.2.5 Subunit vaccines

    5.2.6 DNA vaccines

    5.2.7 Conjugate vaccines

    Geographical Analysis

    6.1 Introduction

    6.2 U.K

    6.3 Spain

    6.4 Germany

    6.5 Italy

    6.6 France

    Strategic Analysis

    7.1 PESTLE analysis

    7.1.1 Political

    7.1.2 Economic

    7.1.3 Social

    7.1.4 Technological

    7.1.5 Legal

    7.1.6 Environmental

    7.2 Porter’s Five analysis

    7.2.1 Bargaining Power of Suppliers

    7.2.2 Bargaining Power of Consumers

    7.2.3 Threat of New Entrants

    7.2.4 Threat of Substitute Products and Services

    7.2.5 Competitive Rivalry within the Industry

    Market Leaders' Analysis

    8.1 Bayer Healthcare AG

    8.1.1 Overview

    8.1.2 Product Analysis

    8.1.3 Strategic Evaluation and Operations

    8.1.4 Financial analysis

    8.1.5 Legal issues

    8.1.6 Recent Developments

    8.1.7 SWOT analysis

    8.1.8 Analyst View

    8.2 Bioniche Animal Health Canada

    8.3 Sanofi Animal Health Inc.

    8.4 Biogenesis Bago SA

    8.5 Heska Corporation

    8.6 Indian Immunologicals Ltd.

    8.7 Boehringer Ingelheim GmbH

    8.8 Novartis Animal Health, Inc.

    8.9 Merck & Co. Inc.

    8.10 Protein Sciences

    Competitive Landscape

    9.1 Market share analysis

    9.2 Merger and Acquisition Analysis

    9.3 Agreements, collaborations and Joint Ventures

    9.4 New Product Launches

    Expert Opinions

    10.1 Market Outlook

    10.2 Investment Opportunities

    Appendix

    List of Tables

    List of Figures

Additional Details

Publisher

Market Data Forecast

Publisher Information

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Reference

49378 | Europe Veterinary Vaccines Market

Number of Pages

138

Report Format

PDF

Market Data Forecast Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Pentax Europe GmbH - Medical Equipment - Deals and Alliances Profile
SummaryPentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corporation is a research based med...
15 Apr 2016 by Global Data USD $250 More Info
Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc. is a pharm...
09 Mar 2016 by Global Data USD $250 More Info
Pentax Europe GmbH - Medical Equipment - Deals and Alliances Profile
SummaryPentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corporation is a research based med...
25 Feb 2016 by Global Data USD $250 More Info
Fujirebio Europe N.V. - Strategic SWOT Analysis Review
Fujirebio Europe N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the com...
19 Jan 2016 by Global Data USD $125 More Info
Bespak Europe Ltd. - Product Pipeline Analysis, 2015 Update
SummaryBespak Europe Ltd. (Bespak) is a medical device company. It supplies drug delivery devices fo...
17 Dec 2015 by Global Data USD $750 More Info
Physician Views: As off-label Avastin use threatens to increase in Europe, where next for wet AMD therapies?
Scope The market for wet age-related macular degeneration (AMD) therapies retains significant commer...
16 Jul 2014 by FirstWord Pharma USD $695 More Info
Oncology Market Access Europe – Payer and Industry Perspectives
IntroductionOncology Market Access Europe – Payer and Industry Perspectives answers your questions:W...
03 Jul 2014 by FirstWord Pharma USD $995 More Info
The Reality of Market Access in Europe: the role of Health Technology Assessment
IntroductionFaced with slipping or negligible GDP growth and an economic crisis, Eurozone countries ...
10 Mar 2014 by FirstWord Pharma USD $695 More Info
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Biosimilar Remicade poised for approval in Europe – are rheumatologists and gastroenterologists ready?
ScopeThe recent recommendation to approve a biosimilar version of Merck & Co./Johnson & Johnson's Re...
01 Jul 2013 by FirstWord Pharma USD $695 More Info

This report is published by Market Data Forecast

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Download Free Report Summary PDF

Europe Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) [Report Updated: 01-12-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...